Related Experiment Video
Updated: Mar 17, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018
Triggering Intracellular Receptors for Vaccine Adjuvantation
Alice Gutjahr1, Gérard Tiraby2, Eric Perouzel2
1Laboratoire de Biologie Tissulaire et d'Ingénierie Thérapeutique, Unité Mixte de Recherche 5305, Université Lyon 1, Centre National de la Recherche Scientifique (CNRS), Institut de Biologie et Chimie des Protéines (IBCP)-Lyon, France; InvivoGen, Toulouse, France; Groupe Immunité des Muqueuses et Agents Pathogènes, Institut National de la Santé et de la Recherche Médicale (INSERM) Centre d'Investigation Clinique 1408 Vaccinologie, Faculté de Médecine de Saint-Etienne-Saint-Etienne, France.
Next-generation vaccine adjuvants leverage innate immunity by targeting endosomal and intracellular receptors. This approach enhances immune responses, guiding them toward specific outcomes like cytotoxic or mucosal immunity.
Area of Science:
- Immunology
- Vaccinology
- Molecular Biology
Background:
- Immune adjuvants are crucial for vaccine efficacy, stimulating or modulating immune responses.
- Recent advances in innate immunity research have enabled the development of novel adjuvants.
- Targeting specific receptors is key to designing advanced vaccine components.
Purpose of the Study:
- To review the role of targeting endosomal and intracellular receptors in vaccine adjuvant design.
- To present and compare current molecules and combinations for next-generation adjuvants.
- To highlight how receptor targeting can direct specific immune responses.
Main Methods:
- Literature review of recent advancements in adjuvant research.
- Analysis of molecules targeting endosomal and intracellular receptors.
- Comparison of different adjuvant strategies and their potential combinations.
Main Results:
- Targeting endosomal and intracellular receptors offers a powerful strategy for enhancing vaccine-induced immunity.
- Specific receptor engagement can direct immune responses towards desired outcomes (e.g., cytotoxic, mucosal).
- Various molecules and combinations are emerging as promising next-generation adjuvants.
Conclusions:
- Strategic targeting of innate immune receptors is central to developing effective next-generation vaccines.
- Understanding receptor-ligand interactions allows for precise control over the type and strength of immune responses.
- This approach holds significant potential for both prophylactic and therapeutic vaccine applications.
Related Concept Videos
Vaccinations
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Intracellular Signaling Cascades
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Cell-mediated Immune Responses
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...

